MD & B is a supermarket in Zemst. Private Limited, started on 27 July 2005, 1 establishment.

What is the address of MD & B?

The registered office of MD & B is located at Rubenslaan 1, 1982 Zemst.

Is MD & B still active?

Yes. According to the CBE (30 October 2026) MD & B is active, legal situation “Normale toestand”, started on 27 July 2005.

Is MD & B registered on Peppol?

Yes, MD & B is registered on the Peppol network with ID 0208:0875277025.

What is the enterprise number of MD & B?

The enterprise number of MD & B is BE0875277025.

When was MD & B founded?

MD & B was founded on 27 July 2005.

Who are the directors of MD & B?

According to the 2025 annual accounts, the directors of MD & B are: Tim Anthonis, Steven Stouten, ZIBO BV.

Is MD & B a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 27 July 2005; 5 annual accounts filed, latest fiscal year 2025; 3 directors known from the annual account.

How much profit did MD & B make in 2025?

MD & B posted a profit after taxes of € 843,592 in financial year 2025.

What is the revenue of MD & B?

As a small company, MD & B is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 2,852,749.

How much does an employee at MD & B earn?

The average wage cost per full-time employee at MD & B was € 43,000 in 2025: staff costs of € 1.1 million for 26.1 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does MD & B have?

According to the 2025 annual accounts, MD & B has 26.1 full-time equivalents (FTE).

MD & B (Private Limited) - Zemst - BE0875277025

Dossier MD & B, printed on 30 October 2026 from databakkes.be/en/0875277025/md-b. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

MD & B from Zemst, company number BE0875277025, closed financial year 2025 with a result of € 843,592 after tax. For that financial year MD & B recorded a gross margin of € 2.9 million and equity of € 4.6 million. Compared with financial year 2024, the result moved from € 557,201 to € 843,592. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 28, 2026.

What it is worth Growing

€ 4.6 million

▲ 10% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 843,592

▲ 51% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 1.9 million

▲ 124% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 438,401 paid out

52 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents

26.1

▼ 0.5 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 1.1 million

€ 43,000 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 2.8 million

▼ 6% vs 2024

Of which on lease € 2.8 million.

Debts at end 2025

Bank debt ≈ 4 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 1.7 million

▼ 17% vs 2024

€ 385,578 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.

Owed to suppliers

€ 372,356

▼ 2% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 177,719

▼ 44% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 2,404,366 Gross margin 2022: € 2,404,366 First fiscal year in the series	€ 2,462,554 Gross margin 2023: € 2,462,554 ▲ 2% vs 2022 (€ 2,404,366) Favourable step	€ 2,324,300 Gross margin 2024: € 2,324,300 ▼ 6% vs 2023 (€ 2,462,554) Unfavourable step	€ 2,852,749 Gross margin 2025: € 2,852,749 ▲ 23% vs 2024 (€ 2,324,300) Favourable step	▲ 23%
Profit after taxes	€ 683,400 Profit after taxes 2022: € 683,400 First fiscal year in the series	€ 767,378 Profit after taxes 2023: € 767,378 ▲ 12% vs 2022 (€ 683,400) Favourable step	€ 557,201 Profit after taxes 2024: € 557,201 ▼ 27% vs 2023 (€ 767,378) Unfavourable step	€ 843,592 Profit after taxes 2025: € 843,592 ▲ 51% vs 2024 (€ 557,201) Favourable step	▲ 51%
Equity	€ 3,648,829 Equity 2022: € 3,648,829 First fiscal year in the series	€ 4,416,207 Equity 2023: € 4,416,207 ▲ 21% vs 2022 (€ 3,648,829) Favourable step	€ 4,168,851 Equity 2024: € 4,168,851 ▼ 6% vs 2023 (€ 4,416,207) Unfavourable step	€ 4,574,042 Equity 2025: € 4,574,042 ▲ 10% vs 2024 (€ 4,168,851) Favourable step	▲ 10%
Total debts	€ 1,828,965 Total debts 2022: € 1,828,965 First fiscal year in the series	€ 1,574,896 Total debts 2023: € 1,574,896 ▼ 14% vs 2022 (€ 1,828,965) Favourable step	€ 3,985,210 Total debts 2024: € 3,985,210 ▲ 153% vs 2023 (€ 1,574,896) Unfavourable step	€ 3,098,414 Total debts 2025: € 3,098,414 ▼ 22% vs 2024 (€ 3,985,210) Favourable step	▼ 22%
Cash	€ 1,382,483 Cash 2022: € 1,382,483 First fiscal year in the series	€ 701,976 Cash 2023: € 701,976 ▼ 49% vs 2022 (€ 1,382,483) Unfavourable step	€ 847,758 Cash 2024: € 847,758 ▲ 21% vs 2023 (€ 701,976) Favourable step	€ 1,903,048 Cash 2025: € 1,903,048 ▲ 124% vs 2024 (€ 847,758) Favourable step	▲ 124%
Retained profit	€ 3,580,962 Retained profit 2022: € 3,580,962 First fiscal year in the series	€ 4,348,340 Retained profit 2023: € 4,348,340 ▲ 21% vs 2022 (€ 3,580,962) Favourable step	€ 4,100,984 Retained profit 2024: € 4,100,984 ▼ 6% vs 2023 (€ 4,348,340) Unfavourable step	€ 4,506,175 Retained profit 2025: € 4,506,175 ▲ 10% vs 2024 (€ 4,100,984) Favourable step	▲ 10%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 804,557 Dividend 2024: € 804,557 Unchanged (€ 0) Unchanged	€ 438,401 Dividend 2025: € 438,401 ▼ 46% vs 2024 (€ 804,557) Unchanged	▼ 46%
Bank debt	€ 900,873 Bank debt 2022: € 900,873 First fiscal year in the series	€ 709,390 Bank debt 2023: € 709,390 ▼ 21% vs 2022 (€ 900,873) Favourable step	€ 2,080,430 Bank debt 2024: € 2,080,430 ▲ 193% vs 2023 (€ 709,390) Unfavourable step	€ 1,723,840 Bank debt 2025: € 1,723,840 ▼ 17% vs 2024 (€ 2,080,430) Favourable step	▼ 17%
Balance sheet total	€ 5,477,794 Balance sheet total 2022: € 5,477,794 First fiscal year in the series	€ 5,991,103 Balance sheet total 2023: € 5,991,103 ▲ 9% vs 2022 (€ 5,477,794) Unchanged	€ 8,154,061 Balance sheet total 2024: € 8,154,061 ▲ 36% vs 2023 (€ 5,991,103) Unchanged	€ 7,672,456 Balance sheet total 2025: € 7,672,456 ▼ 6% vs 2024 (€ 8,154,061) Unchanged	▼ 6%
Employees (FTE)	28.7 Employees (FTE) 2022: 28.7 First fiscal year in the series	28.2 Employees (FTE) 2023: 28.2 ▼ 0.5 vs 2022 (28.7) Unchanged	26.6 Employees (FTE) 2024: 26.6 ▼ 1.6 vs 2023 (28.2) Unchanged	26.1 Employees (FTE) 2025: 26.1 ▼ 0.5 vs 2024 (26.6) Unchanged	▼ 0.5

Key figures of MD & B, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to MD & B?

What happened at MD & B in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 28, 2026 New annual accounts for financial year 2025: profit of € 843,592 (▲ 51% vs 2024). filed late Source: NBB ↗
2026 Tim Anthonis became a director. NBB
2026 Steven Stouten became a director. NBB
2026 ZIBO BV became a director. NBB
Sep 18, 2005 New establishment in Zemst. KBO
Jul 27, 2005 Start of the company according to the CBE. KBO

In short

From € 683,400 profit in 2022 to € 843,592 profit in 2025.

Paid € 966,212 in corporate taxes since 2022.

Best year ever: 2025, with € 843,592 profit.

On average € 109,300 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

Daisy Alleman

ZIBO

Diederik Moriau

MD & B

Behind MD & B are Tim Anthonis, Steven Stouten and ZIBO BV. The shares are held by Daisy Alleman, ZIBO and Diederik Moriau.

Directors

According to the 2025 annual accounts

Tim Anthonis

Wettelijke vertegenwoordiger

Also active at: N.V. CUYPERS, ZIBO, MABRI, ASTS, ANTHEM, STIM, BLANG RETAIL

since 2026

Steven Stouten

Director

Also active at: N.V. CUYPERS, MABRI, ASTS, ANTHEM, STIM, BLANG RETAIL

since 2026

ZIBO BV

Director · represented by Tim Anthonis

Also active at: N.V. CUYPERS, MABRI, ASTS, ANTHEM, STIM, BLANG RETAIL

since 2026

Shareholders

Daisy Alleman

ZIBO

Diederik Moriau

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Rubenslaan 1

1982 Zemst

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0875.277.025

VAT number

BE 0875.277.025

Registered office

Rubenslaan 1, 1982 Zemst

Names & denominations

MD & B

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

27 July 2005

Peppol

Active · Active since 24 Nov 2023

Activities · NACE

Niet-gespecialiseerde detailhandel waarbij voedings- en genotmiddelen overheersen

Supermarkten (verkoopsoppervlakte tussen 400 m2 en minder dan 2.500 m2)

Detailhandel in niet-gespecialiseerde winkels waarbij voedings- en genotmiddelen overheersen (verkoopsoppervlakte tussen 400 m² en minder dan 2500 m²)

View on CBE Public ↗ Annual accounts (NBB) ↗

MD & B

Financials

What happened to MD & B?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Details

Frequently asked questions